284 Results

People

  1. Moore
    Moore
  2. Cheung
    Cheung
  3. Kushner
    Kushner
  4. Golde
    Golde
  5. Modak
    Modak
  6. Allison
    Allison
  7. Wolchok
    Wolchok
  8. O'Reilly
    O'Reilly
  9. Slovin
    Slovin
  10. Fong
    Fong

Groups

  1. Department of Medicine (122)
  2. Hematologic Malignancies, Division of (72)
  3. GSK Faculty (71)
  4. Sloan Kettering Institute Faculty (69)
  5. Solid Tumor Oncology Division (54)
  6. Center for Hematologic Malignancies (49)
  7. Pediatrics, Department of (47)
  8. Tow Center for Developmental Oncology (TCDO) (44)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (42)
  10. Center for Molecular Imaging and Biotechnology (31)
  1. "granulocyte macrophage colony stimulating factor"
Formats
  1. Journal Article (265)
  2. Conference Paper (11)
  3. Review (5)
  4. Book Section (1)
  5. Editorial (1)
  6. Meeting Abstract (1)
Groups
  1. Department of Medicine (122)
  2. Hematologic Malignancies, Division of (72)
  3. GSK Faculty (71)
  4. Sloan Kettering Institute Faculty (69)
  5. Solid Tumor Oncology Division (54)
  6. Center for Hematologic Malignancies (49)

More Groups

People
  1. Malcolm Moore (29)
  2. Nai-Kong Cheung (25)
  3. Brian Kushner (18)
  4. Jedd Wolchok (18)
  5. David Golde (14)
  6. Shakeel Modak (14)

More People

Years
  1. 2025 (1)
  2. 2024 (9)
  3. 2023 (3)
  4. 2021 (2)
  5. 2020 (4)
  6. 2019 (1)

More Years

Publications
  1. Blood (23)
  2. Journal of Clinical Oncology (11)
  3. Clinical Cancer Research (9)
  4. Bone Marrow Transplantation (8)
  5. Seminars in Oncology (8)
  6. Cancer (7)

More Publications

Publishers
  1. Elsevier Inc. (28)
  2. Nature Publishing Group (26)
  3. American Society of Hematology (23)
  4. American Association for Cancer Research (17)
  5. Lippincott Williams & Wilkins (17)
  6. Springer (17)

More Publishers

Results (284)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Local secretion of anti-CTLA-4 enhances the therapeutic efficacy of a cancer immunotherapy with reduced evidence of systemic autoimmunity
    Journal Article

    Simmons, A. D.; Moskalenko, M.; Creson, J.; Fang, J.; Yi, S.; VanRoey, M. J.; Allison, J. P.; Jooss, K.
    Cancer Immunology, Immunotherapy (2008)

    Fulltext@MSK | Save
  • Prospective tracing of MLL-FRYL clone with low MEIS1 expression from emergence during neuroblastoma treatment to diagnosis of myelodysplastic syndrome
    Journal Article

    Robinson, B. W.; Cheung, N. K. V.; Kolaris, C. P.; Jhanwar, S. C.; Choi, J. K.; Osheroff, N.; Felix, C. A.
    Blood (2008)

    Fulltext@MSK | Save
  • Phase I/II study of GM-CSF DNA as an adjuvant for a multipeptide cancer vaccine in patients with advanced melanoma
    Journal Article

    Perales, M. A.; Yuan, J.; Powel, S.; Gallardo, H. F.; Rasalan, T. S.; Gonzalez, C.; Manukian, G.; Wang, J.; Zhang, Y.; Chapman, P. B.; more...
    Molecular Therapy (2008)

    Fulltext@MSK | Save
  • Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy
    Journal Article

    Peggs, K. S.; Quezada, S. A.; Allison, J. P.
    Immunological Reviews (2008)

    Fulltext@MSK | Save
  • Cancer vaccines: An overview
    Journal Article

    Old, L. J.
    Cancer Immunity (2008)

    Fulltext@MSK | Save
  • Is it important to decipher the heterogeneity of "normal karyotype AML"?
    Journal Article

    Nimer, S. D.
    Best Practice and Research: Clinical Haematology (2008)

    Fulltext@MSK | Save
  • A pilot vaccination trial of synthetic analog peptides derived from the BCR-ABL breakpoints in CML patients with minimal disease
    Journal Article

    Maslak, P. G.; Dao, T.; Gomez, M.; Chanel, S.; Packin, J.; Korontsvit, T.; Zakhaleva, V.; Pinilla-Ibarz, J.; Berman, E.; Scheinberg, D. A.
    Leukemia (2008)

    Fulltext@MSK | Save
  • Herpes simplex virus NV1020 as a novel and promising therapy for hepatic malignancy
    Journal Article

    Kelly, K. J.; Wong, J.; Fong, Y.
    Expert Opinion on Investigational Drugs (2008)

    Fulltext@MSK | Save
  • CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4 + T cells in a dose-dependent fashion
    Journal Article

    Kavanagh, B.; O'Brien, S.; Lee, D.; Hou, Y.; Weinberg, V.; Rini, B.; Allison, J. P.; Small, E. J.; Fong, L.
    Blood (2008)

    Fulltext@MSK | Save
  • Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
    Journal Article

    Hodi, F. S.; Butler, M.; Oble, D. A.; Seiden, M. V.; Haluska, F. G.; Kruse, A.; MacRae, S.; Nelson, M.; Canning, C.; Lowy, I.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2008)

    Fulltext@MSK | Save